| [1] |
.
[J]. Clinical Focus, 2024, 39(1): 75-79.
|
| [2] |
Duan Fang, Cui Wei.
Application principles of vasodilators in the treatment of acute heart failure
[J]. Clinical Focus, 2023, 38(9): 773-778.
|
| [3] |
.
[J]. Clinical Focus, 2023, 38(9): 832-837.
|
| [4] |
.
[J]. Clinical Focus, 2023, 38(6): 573-576.
|
| [5] |
.
[J]. Clinical Focus, 2023, 38(5): 459-464.
|
| [6] |
Wang Zhen, Yang Xiaoyue, Li Shaojie, Wang Xian, Chen Shuxia, Gu Jian.
Analysis of clinical characteristics and readmission risk factors in patients with ejection fraction preserved heart failure combined with atrial fibrillation
[J]. Clinical Focus, 2023, 38(4): 308-314.
|
| [7] |
.
[J]. Clinical Focus, 2023, 38(4): 369-372.
|
| [8] |
Zuo Xiuxiu, Hou Tianhua, Wang Hongxiang.
Effect of subclinical hypothyroidism on prognosis of patients with chronic systolic heart failure: A meta-analysis
[J]. Clinical Focus, 2022, 37(10): 905-911.
|
| [9] |
.
[J]. Clinical Focus, 2022, 37(9): 838-841.
|
| [10] |
Li Heng, Li Yonghui, Sun Xiaoqiang, Wang Lin, He Feng.
Efficacy and safety of anticoagulant therapy for patients with heart failure in sinus rhythm
[J]. Clinical Focus, 2022, 37(5): 406-411.
|
| [11] |
Luo Fanglin, Guan Suying, Wu Guoxiang.
Clinical effect of sacubitril-valsartan combined with activin on acute left heart failure
[J]. Clinical Focus, 2021, 36(9): 782-785.
|
| [12] |
.
[J]. Clinical Focus, 2021, 36(7): 641-645.
|
| [13] |
Zhao Meili, Xiao Liyuan, Liu Lin, Kang Chao, Zhang Qiuxiang.
Correlation between NT-proBNP, hs-CRP, left atrium diameter and chronic heart failure concurrent with atrial fibrillation
[J]. Clinical Focus, 2021, 36(5): 412-415.
|
| [14] |
Xu Dongrui, Zhao Qinhui, Liu Tongxiang.
Clinical effect of sacubitril/valsartan for heart failure with mid-range ejection fraction in left ventricle
[J]. Clinical Focus, 2021, 36(5): 416-420.
|
| [15] |
Bai Lian, Guo Peng, Luan Bo, Bai Hao, Jiang Shan.
Correlation between serum free fatty acid and cardiac function in patients with acute heart failure
[J]. Clinical Focus, 2021, 36(3): 208-211.
|
